Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

SANGEETA D SEHGAL

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1992766224
CMS profile
90066
Location
VALPARAISO, IN

General Payments · PY2018–2024

$3,217.70

  • Reported across 124 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$611.09

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $611.09 14

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Amgen Inc. $175.00 4
ABIOMED $137.30 1
BOSTON SCIENTIFIC CORPORATION $125.00 1
ABBVIE INC. $71.64 3
PFIZER INC. $47.84 2
Novo Nordisk AS $19.34 1
Sumitomo Pharma America, Inc. $18.92 1
Otsuka America Pharmaceutical, Inc. $16.05 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $527.60 31
PY2019 $813.07 22
PY2020 $69.30 5
PY2021 $407.15 13
PY2022 $296.01 23
PY2023 $493.48 16
PY2024 $611.09 14

Payment records · PY2024 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $28.01 05/15/2024 Food and Beverage Undisputed 01/23/2026 1106052414 CMS
ABBVIE INC. $28.01 07/12/2024 Food and Beverage Undisputed 01/23/2026 1106052416 CMS
ABBVIE INC. $15.62 08/12/2024 Food and Beverage Undisputed 01/23/2026 1106052418 CMS
ABIOMED $137.30 01/31/2024 Food and Beverage Undisputed 01/23/2026 1142246717 CMS
Amgen Inc. $125.00 02/17/2024 Food and Beverage Undisputed 01/23/2026 1116100825 CMS
Amgen Inc. $14.41 06/18/2024 Food and Beverage Undisputed 01/23/2026 1116100805 CMS
Amgen Inc. $12.59 08/27/2024 Food and Beverage Undisputed 01/23/2026 1116100811 CMS
Amgen Inc. $23.00 10/29/2024 Food and Beverage Undisputed 01/23/2026 1116100817 CMS
Boston Scientific Corporation $125.00 01/04/2024 Food and Beverage Undisputed 01/23/2026 1092513303 CMS
Novo Nordisk Inc $19.34 07/16/2024 Food and Beverage Undisputed 01/23/2026 1097418274 CMS
Otsuka America Pharmaceutical, Inc. $16.05 09/24/2024 Food and Beverage Undisputed 01/23/2026 1118978590 CMS
PFIZER INC. $27.20 08/02/2024 Food and Beverage Undisputed 01/23/2026 1131875481 CMS
PFIZER INC. $20.64 11/21/2024 Food and Beverage Undisputed 01/23/2026 1131147606 CMS
Sumitomo Pharma America, Inc. $18.92 02/15/2024 Food and Beverage Undisputed 01/23/2026 1148917044 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.